Partnering
Strategic collaborations to advance EL-924.
Elaphron is open to strategic collaborations to advance the development of EL-924 and related metabolic disease programs.
Areas of interest
Where we partner.
Co-development
Advance EL-924 across indications and geographies.
Combination strategy
Pair EL-924 with complementary metabolic therapies.
Translational research
Joint preclinical and early clinical programs EL 924 and EL156 .